Frequency of cannabis use during pregnancy and adverse infant outcomes, by cigarette smoking status – 8 PRAMS states, 2017
Sarah C. Haight, Jean Y. Ko(National Center for Chronic Disease Prevention and Health Promotion), Cynthia Ferré(National Center for Chronic Disease Prevention and Health Promotion), Jennifer M. Bombard(National Center for Chronic Disease Prevention and Health Promotion), Althea M. Grant(Centers for Disease Control and Prevention), Kelsey C. Coy, Brian A. King(United States Food and Drug Administration)
Cited by 49
Related Papers
National Estimates of Marijuana Use and Related Indicators — National Survey on Drug Use and Health, United States, 2002–2014
|MMWR Surveillance Summaries|2016|465
Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization — United States, 2017–2019
|MMWR Morbidity and Mortality Weekly Report|2022|442
ATPase and Multidrug Transport Activities of the Overexpressed Yeast ABC Protein Yor1p
|Journal of Biological Chemistry|1998|390
Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021
|Preventing Chronic Disease|2021|370
Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury — United States, October 2019
|MMWR Morbidity and Mortality Weekly Report|2019|265